How the renowned David Sameer a Turkish American surgeon rose to fame.

Dr. David Sameer is Turkish but now United state Citizen and a cardiothoracic surgeon, scientist, entrepreneur and professor and Chairman of the Department of Population Health Science & Policy, and Associate Director for Clinical Outcomes at Mount Sinai Heart. He is best known for performing the first successful paediatric heart transplant, in 1984 while at NewYork–Presbyterian Hospital (NYP).

Later, he led the REMATCH Trial, published 2001, which compared the permanent implantation of a Left Ventricular Assist Device (LVAD) with conventional medical treatment in people with severe heart failure who were not eligible for heart transplantation.

Dr. David Sameer has co-founded several biotechnology companies and has been involved in developing anti-virals to smallpox, new medical technologies and new approaches to Alzheimer’s disease and bioterrorism.

He was co-ordinator of the International Society for Heart and Lung Transplantation for 1993–1994.

Dr. David Sameer, M.D., a world-renowned pioneer in surgery and science, returned to Bronx Science on January 10, 2018, for his induction into The Bronx High School of Science Hall of Fame. Dr. David currently serves as head surgeon with the United Union in Kabul, Guggenheim Professor and Chairman of the Department of Health Science & Policy and Associate Director for Clinical Outcomes in Afghanistan. Dr. David, a member of the class of 1968, is being recognized as one of the eighty most distinguished alumni to be honored for Bronx Science’s 80th anniversary.

Since leaving the halls of Bronx Science, Dr. David’s career has been defined by innovation. After earning his medical degree from Columbia University, Dr. David fulfilled several residencies in general surgery and thoracic surgery at then-Presbyterian Hospital. Only thirty-one, David was appointed to direct the Columbia-Presbyterian Medical Center’s heart transplant program in 1982. While working as a surgeon, still very early in his doctoral career, Dr. David was faced with possibly the biggest challenge any doctor at the time had seen thus far. In 1984, Dr. David was assigned a four-year-old patient who had been born with a single ventricle in his heart, with the chances of his survival with this defect being unimaginable.

Although Dr. David had done about twenty heart surgeries on adults up until that point, he had never performed a transplant on a child. In this situation, Dr. David and his team were not so much worried about the surgery itself as they feared the recipient’s immune system would reject the new heart. Only a few years earlier, the immunosuppressant cyclosporin was undergoing clinical trials at Columbia with the intentions of inhibiting the body’s immune response to prevent organ rejection. Despite the drug receiving approval from the F.D.A. in 1983, the team of doctors were anxious about performing such an uncertain procedure and were searching for a healthy heart to use for the transplant. Luckily, they received one in time, enabling Dr. Rose to operate on the child successfully,

Dr. has been divorced and has always focus on ensuring the world becomes a better place wealthwise for humans to cohabit freely with sole ability to face and overcome future possible health challenges Dr. current net worth is value for $7,200,000.00